SEC Form 4 · accession 0001493152-16-007869
Targeted Medical Pharma, Inc. · TRGM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kim Giffoni
Officer — Chief Executive Officer · Director · 10% Owner
Period of report
Mar 4, 2016
Accepted (ET)
Mar 7, 2016 · 4:58 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001420030
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 4, 2016 | A | 547,500 | $0.05 | A | 751,095 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to Purchase Common StockF1 | $0.05 | Mar 4, 2016 | A | 300,000 | A | — | Mar 3, 2023 | Common Stock | 300,000 | 300,000 | D |
Explanation of responses
- F1The options were issued pursuant to the Company's 2011 Stock Incentive Plan. Options to purchase 300,000 shares vested on March 4, 2016 with a seven year term.